Login
Navigate Fool.com
Will CGEN beat
the market?

Compugen Ltd. (USA)

NASDAQ: CGEN

Community Rating: 3 Stars: Appealing

9.71 0.54 (5.89%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.25
Previous Close $9.17
Daily Range $9.17 - $9.78
52-Week Range $4.90 - $14.32
Market Cap $383.3M
P/E Ratio -25.47
Dividend (Yield) $0.00 (0.0%)
Volume 239,930
Average Daily Volume 450,899
Current FY EPS -$0.51

How do you think CGEN
will perform against the market?

Top CGEN Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

Why Compugen Ltd. Shares Got Hammered

Compugen shares tank after announcing a secondary share offering. Is this the opportunity investors have been waiting for or a reason to keep your distance?

Sector Update: Healthcare Shares Flat Pre-Market; Compugen Rallies 4% on Buy Rating at Jefferies

Sector Update: Healthcare

Compugen Presents Experimental Results Supporting Induction of Immune Tolerance by CGEN-15001 Drug C

Compugen Target for Cancer Immunotherapy Shown to Affect Multiple Immune Cell Types Involved in Tumo

Compugen Establishes Scientific Advisory Board to Guide Pipeline Program Development

This Week in Biotech

EU approvals, FDA rejections, and the ongoing courtship of Onyx Pharmaceuticals highlight three of this week's biggest biotech events.

Market Wrap For Monday, August 5: Stocks Close Mixed; Nasdaq Rises, Dow And S&P Fall Modestly

Why Compugen Shares Skyrocketed

Even shareholders realize that two heads are better than one!

Monday’s movers: Tyson, PPL Corp.

See More CGEN News...

Sector

Healthcare

Industry

Drugs

Compugen Ltd. (USA) (CGEN) Description

A biotechnology discovery company focused on discovering and licensing of product candidates to the drug and diagnostic industry. Website: http://www.cgen.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks